Literature DB >> 4230990

[Experimental studies with cyclic imides in dimethylbenzanthracene tumors of Sprague-Dawley rats].

H Mückter, E Frankus, E Moré, W E Kollmer, M Staemmler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4230990

Source DB:  PubMed          Journal:  Z Krebsforsch        ISSN: 0301-1585


× No keyword cloud information.
  10 in total

1.  THE RELATION BETWEEN THE URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS AND THE FATE OF PATIENTS AFTER MASTECTOMY.

Authors:  R D BULBROOK; J L HAYWARD; B S THOMAS
Journal:  Lancet       Date:  1964-05-02       Impact factor: 79.321

2.  THE HORMONE-DEPENDENT CANCERS.

Authors:  C HUGGINS
Journal:  JAMA       Date:  1963-11-02       Impact factor: 56.272

3.  CLINICAL EXPERIENCES WITH THALIDOMIDE IN PATIENTS WITH CANCER.

Authors:  H GRABSTALD; R GOLBEY
Journal:  Clin Pharmacol Ther       Date:  1965 May-Jun       Impact factor: 6.875

4.  PROPOSITIONS IN HORMONAL TREATMENT OF ADVANCED CANCERS.

Authors:  C B HUGGINS
Journal:  JAMA       Date:  1965-06-28       Impact factor: 56.272

5.  TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE: EFFECT ON CLINICAL SYMPTOMS, MORPHOLOGY, AND ENDOCRINE FUNCTION.

Authors:  J GELLER; R BORA; T ROBERTS; H NEWMAN; A LIN; R SILVA
Journal:  JAMA       Date:  1965-07-12       Impact factor: 56.272

6.  Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression.

Authors:  C HUGGINS; L C GRAND; F P BRILLANTES
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

7.  [Thalidomide and cancer].

Authors:  H Mückter; E Moré
Journal:  Arzneimittelforschung       Date:  1966-02

Review 8.  Functions of the cancer cell.

Authors:  C Huggins
Journal:  Z Krebsforsch       Date:  1965

9.  Evaluation of chemotherapeutic agents in mammary carcinoma induced by 3-methylcholanthrene in Wistar rats.

Authors:  A P Davis; M Gruenstein; M B Shimkin
Journal:  Cancer Res       Date:  1966-02       Impact factor: 12.701

10.  THALIDOMIDE (N-PHTHALOYLGLUTAMIMIDE) IN THE TREATMENT OF ADVANCED CANCER.

Authors:  K B OLSON; T C HALL; J HORTON; C L KHUNG; H F HOSLEY
Journal:  Clin Pharmacol Ther       Date:  1965 May-Jun       Impact factor: 6.875

  10 in total
  2 in total

1.  [Morphological changes of the pituitary gland and adrenal cortex in rats after application of hormonally active substances for the treatment of DMBA-induced mammary tumors].

Authors:  E Hagen; W Wittkowski; P A Stöhr
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

2.  The effect of two soluble thalidomide derivatives on lymphocyte stimulation.

Authors:  A S Coulson; L J Summers; K Lindahl-Kiessling; D Tucker; K Hellmann
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.